Roche, Shire court fight escalates over haemophilia drug
December 16, 2017 at 04:57 AM EST
ZURICH, Dec 16 (Reuters) - Roche's patent dispute with London-listed Shire over the Swiss drugmaker's new haemophilia drug Hemlibra has escalated, with Shire filing a new motion in a U.S. court that Roche says aims to stop some patients from getting its medicine.